Last reviewed · How we verify
Desopan (TRILOSTANE)
At a glance
| Generic name | TRILOSTANE |
|---|---|
| Sponsor | Bioenvision |
| Drug class | trilostane |
| Target | 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
| First approval | 1984 |
Approved indications
- Hypercortisolism
Common side effects
Key clinical trials
- Randomized Study of Letrozole and Trilostane for Medical Abortion (PHASE2)
- Trilostane for Androgen-Independent Prostate Cancer (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |